ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 157995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 157995; 2) Community: the network communities that were significantly associated with the response to NSC 157995; 3) Molecule: the relationships between components within communities and NSC 157995; 4) MDR: the compounds that were significantly associated with the NSC 157995.

NSC Compound Enrichment Correlation
NSC 642913 Null 0.0102077332082016 0.42280464
NSC 684438 Null 0.0102077332082016 0.24670395
NSC 703467 Null 0.0102077332082016 -0.052894392
NSC 718809 Null 0.0102077332082016 0.3141999
NSC 720147 Null 0.0102077332082016 -0.0036002012
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0102077332082017 0.17904439
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0102077332082017 0.24066466
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.011234153078014 0.41039173
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.011234153078014 0.30814379
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.011234153078014 -0.034553689
Total:54  Current:12    [First] [Prev] [Next] [Last]